This is a real-world medical entrance exam question, please give the true answer based on the question and selection. Topic name: None, Subject name: Pharmacology
[{'content': 'MOA of Teduglutide in sho bowel syndrome? \nSelect and explain. \nA. GLP-2 inhibitor, B. HT1a inhibitor, C. GLP-1 analogs, D. C-peptide analogs', 'role': 'user'}, {'content': 'Answer: A \nExplanation: Ans. A. GLP-2 inhibitorGlucagon-like peptide-2 (GLP-2) - Impoant intestinotrophic growth factor & mediator of intestinal adaptation.FDA approved teduglutide (Gattex--NPS) to treat sho bowel syndrome in adult patients requiring additional nutrition from I.V. parenteral nutrition.Effectively improves fluid absorption.', 'role': 'assistant'}]